PROFESSOR KINGSTON MILLS  is Professor of Experimental Immunology at TCD.  He has said that vaccinating the entire Irish population is needed to generate herd immunity for Covid-19.  In 2016, Mills began work on a €28 million project to find a vaccine for whooping cough.

He was co-founder of Opsoma Therapeutics with Luke O’Neill. Opsona Therapeutics, one of the most heavily backed Irish biotech start-ups, is to be wound up after 14 years in which it raised more than €76,500.000 in funding.   A decision was taken to put the company into a creditors’ voluntary liquidation after the search for a development partner or buyer for its main drug therapy was fruitless. – 13 Jan 2019

If Pharma are funding all the professors and scientists that the media insist on pushing at us on a daily basis, and pharma stands to benefit from the treatments and vaccines which are being made mandatory – should we be trusting those professors, scientists and media? Here is what the British Medical Journal has to say.

Kingston Mills among top researchers to win 2020 Trinity Innovation Awards – 2 Dec 2020

 

Minister for Further and Higher Education, Innovation and Science, Simon Harris, TD, has today announced a €4.8 million investment into the immunology of COVID-19 at Trinity College Dublin.  The partnership supported by Science Foundation Ireland (SFI) will be led by Prof Kingston Mills and Prof Aideen Long at the Trinity Biomedical Sciences Institute and Trinity Translational Medicine Institute, Trinity College Dublin.